Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Medifast (MED) Revenue (2016 - 2025)

Medifast's Revenue history spans 16 years, with the latest figure at $75.1 million for Q4 2025.

  • For Q4 2025, Revenue fell 36.9% year-over-year to $75.1 million; the TTM value through Dec 2025 reached $385.8 million, down 35.96%, while the annual FY2025 figure was $385.8 million, 35.96% down from the prior year.
  • Revenue reached $75.1 million in Q4 2025 per MED's latest filing, down from $89.4 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $453.3 million in Q2 2022 to a low of $75.1 million in Q4 2025.
  • Average Revenue over 5 years is $259.2 million, with a median of $266.0 million recorded in 2023.
  • Peak YoY movement for Revenue: surged 90.89% in 2021, then tumbled 49.93% in 2024.
  • A 5-year view of Revenue shows it stood at $377.8 million in 2021, then dropped by 10.74% to $337.2 million in 2022, then plummeted by 43.36% to $191.0 million in 2023, then plummeted by 37.7% to $119.0 million in 2024, then crashed by 36.9% to $75.1 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Revenue are $75.1 million (Q4 2025), $89.4 million (Q3 2025), and $105.6 million (Q2 2025).